Gunzburg estimated the chance of infection with "omicron" with the introduction of a nasal vaccine

The use of a nasal vaccine against CORONAVIRUS will eliminate the severe form of the disease in patients with the omicron strain and the very possibility of infection with it. This was stated by the HEAD of the Gamaleya Center that developed the drug, Alexander Gintsburg, on the air of the Rossiya 24 TV channel.

“The possibility of mass use of the nasal vaccine, from our point of view, from the point of view of the developers, will protect people not only from severe forms caused by the micron, but also the possibility of infection and infection,” he said.

According to him, another drug that was developed at the center, the Russian Sputnik V vaccine, protects only against severe forms of the omicron course, but not against infection with it.